PAM
ORMP icon

Panagora Asset Management’s Oramed Pharmaceuticals ORMP Stock Holding History

Panagora Asset Management’s Portfolio ORMP Stock Details ORMP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-411
Closed -$5K – 2178
2021
Q2 		$5K Sell
411
-96
-19% -$1.1K ﹤0.01% 2488
2021
Q1 		$5K Hold
507
– – ﹤0.01% 2585
2020
Q4 		$2K Buy
+507
New +$1.65K ﹤0.01% 2632
2019
Q3 		– Sell
-12,864
Closed -$46K – 2585
2019
Q2 		$46K Sell
12,864
-100
-0.8% -$353 ﹤0.01% 2101
2019
Q1 		$47K Buy
12,964
+3,705
+40% +$12.3K ﹤0.01% 2053
2018
Q4 		$28K Buy
9,259
+563
+6% +$2.33K ﹤0.01% 2138
2018
Q3 		$42K Buy
+8,696
New +$45.2K ﹤0.01% 2054

Other funds holding ORMP

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
JSMC
Jess S. Morgan & Co Los Angeles, California $115M AUM 16.65% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Calamos Advisors
Calamos Advisors Naperville, Illinois $28.2B AUM 21.78% 1-Year Est. Return
JC
Jetstream Capital Brentwood, Tennessee $1.37M AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Panagora Asset Management's ORMP Position: Q3 2021 in Review

Panagora Asset Management sold out of Oramed Pharmaceuticals (ORMP) in Q3 2021, closing a stake of 411 shares — an estimated $5K sold.

Panagora Asset Management first reported a position in ORMP in Q3 2018 and held it in 7 quarters. The position peaked at $47K in Q1 2019. 93 funds tracked by Wall St. Rank hold ORMP as of Q3 2021.

  • Panagora Asset Management reported no remaining Oramed Pharmaceuticals position as of Q3 2021 after selling out during the quarter.
  • Panagora Asset Management sold 411 Oramed Pharmaceuticals shares in Q3 2021, an estimated $5K.
  • Panagora Asset Management first reported a position in Oramed Pharmaceuticals in Q3 2018 and held it in 7 quarters.
  • Panagora Asset Management's Oramed Pharmaceuticals position peaked at $47K in Q1 2019.
  • 93 funds tracked by Wall St. Rank held Oramed Pharmaceuticals as of Q3 2021.

Based on Panagora Asset Management's 13F filing for Q3 2021, filed 10 Nov 2021.